Simulations Plus And Partners Wins FDA Grant To Validate In Vitro-In Vivo Extrapolation Methods For Complex Formulations
Portfolio Pulse from Benzinga Newsdesk
Simulations Plus, along with its partners, has received an FDA grant to validate in vitro-in vivo extrapolation methods for complex formulations. The collaboration aims to develop alternative methods to assess clinical performance of product variants under different conditions.
October 30, 2024 | 12:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Simulations Plus has been awarded an FDA grant to validate in vitro-in vivo extrapolation methods, which could enhance its reputation and capabilities in pharmaceutical simulations.
The FDA grant is a significant endorsement of Simulations Plus's capabilities in pharmaceutical simulations. This could lead to increased demand for their services and potentially improve their financial performance.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90